ASX Announcements / Media releases
28 June 2022
BCAL Enters US Product Development Agreement with Precion. Read more
1 June 2022
BCAL Presentation Accepted for 2022 ASCO Annual Meeting. Read more
12 May 2022
BCAL Files Foundational Patent Application. Read more
24 Mar 2022
Shareholder Newsletter. Read more
8 Feb 2022
7 February Announcement - Additional Information. Read more
7 Feb 2022
Recent Analysis Significantly Improves Commercial Prospects. Read more
11 Jan 2022
Dr John Hurrell Appointed Chief Executive Officer. Read more
3 Nov 2021
Strong Cohort 4 Testing Data Demonstrates Value of BCAL Test. Read more
21 Oct 2021
Notice of Annual General Meeting and Explanatory Statement. Read more
3 Sep 2021
Australian Clinical Studies Launched. Read more
17 Aug 2021
Market Update. Read more
22 July 2021
Becoming a substantial holder. Read more
21 July 2021
BCAL Diagnostics to list after raising $10m in IPO. Read more